Cite
HARVARD Citation
Yamashita, T. et al. (2021). Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer. Cancer investigation. pp. 251-256. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yamashita, T. et al. (2021). Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer. Cancer investigation. pp. 251-256. [Online].